Clinical Trials Browser

Phase 1 × vadimezan × Thoracic × Clear all

NCT00674102 2020-12-09

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung